Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions
Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions
批准号:
10553208
负责人:
Joshua Glenn Petrie
金额:
$10.62万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-02 至 2023-12-31
关键词:
AcuteAdultBioinformaticsCategoriesClinicalCost Effectiveness AnalysisDangerousnessDataDevelopmentDiagnosisDiagnosticDiagnostic testsDisease OutbreaksDoctor of PhilosophyEffectiveness of InterventionsEpidemiologic MethodsEpidemiologyEtiologyFutureGoalsHealth BenefitHealth Care CostsHealthcareHospitalizationHospitalsIncidenceInfectionInfection ControlInfection preventionInfluenzaInterventionIntervention StudiesKnowledgeLaboratoriesLeadMeasuresMentorsMethodologyMethodsMichiganMissionModelingMolecularMolecular EpidemiologyMorbidity - disease rateNational Institute of Allergy and Infectious DiseaseOutcomeOutcomes ResearchPatient-Focused OutcomesPatientsPreventionPrevention strategyProductivityPublic HealthResearchResearch PersonnelSavingsSensitivity and SpecificitySpecimenTechniquesTechnologyTestingTimeTrainingUniversitiesViralVirusVirus DiseasesWorkadvanced analyticscareercareer developmentcase controlclinical epidemiologycommunity burdencommunity settingcostcost effectivecost effectivenessepidemiology studyflu transmissionhealth care settingsimplementation interventionimplementation strategyimprovedinfection burdeninnovationmathematical modelmolecular diagnosticsmortalitymultidisciplinarynext generation sequencingnovelpathogenpediatric patientspreventprogramsrespiratoryrespiratory infection virusrespiratory virusscreeningskillstransmission processviral transmissionwhole genome
中文摘要
项目摘要/摘要
医院相关呼吸道病毒感染(HA-RVI)导致发病率、死亡率和医疗保健增加
成本,但这些感染往往被低估或误诊,特别是对呼吸道病毒
流行性感冒。HA-RVI通过适当的治疗和感染控制措施是可以预防的,但
不完整的诊断会导致错失干预机会。利用这些机会
可能需要额外的诊断性检测和扩大感染控制措施。这个
目前尚不清楚这些方法在多大程度上具有成本效益。因此,有必要定义
医院环境中呼吸道病毒的负担和临床影响,以提供最佳诊断和治疗
和感染预防策略。该项目的总体目标是支持Josh Petrie博士
发展医疗保健流行病学专业知识、最先进的分子方法和先进的
建模技术。这一目标将通过重点培训和职业发展来实现。
医疗保健流行病学、下一代测序、生物信息学、成本效益分析、
以及由一支优秀的导师团队监督的数学建模。这些技能是由
培训和职业发展目标将通过有指导的研究来加强,以实现
以下具体目标:(1)界定社区获得性疾病和医院感染的流行病学和负担--
相关呼吸道病毒感染和比较病毒种类对临床的影响;(2)提高敏感性
以及病例定义的特异性,以通过结合临床、
流行病学和分子数据;以及(3)确定呼吸道病毒增加的成本效益
利用数学模型筛选和扩大感染控制措施,以减少HA-RVI。完成
将代表着皮特里博士在实现他的目标的道路上的下一步
建立独立研究计划的长期目标,该计划使用多学科实验室和
调查流感和其他呼吸道病毒传播的分析方法。预期中的
拟议项目的研究成果是:1)鉴定呼吸道病毒,除了
流感引起的HA-RVI数量最多,并导致最严重的临床后果;
2)开发方法学,通过整合临床、
流行病学和分子数据;以及3)确定具有成本效益的诊断检测和干预措施
预防HA-RVI的实施战略。拟议的研究具有重要意义,因为它是预期的
这项工作的结果以及以此为基础的未来研究将导致发病率的降低,
死亡率和与HA-RVI相关的医疗费用。这项研究的创新之处在于它关注的是一个
重要呼吸道病毒小组及其跨学科方法的使用,从而允许新的
研究的途径。
英文摘要
PROJECT SUMMARY / ABSTRACT
Hospital-associated respiratory virus infections (HA-RVI) lead to increased morbidity, mortality, and healthcare
costs, but these infections are often under- or misdiagnosed particularly for respiratory viruses other than
influenza. HA-RVI are preventable through appropriate treatment and infection control measures, but
incomplete diagnosis leads to missed opportunities for intervention. Taking advantage of these opportunities
for intervention might require additional diagnostic testing and expanded infection control measures. The
degree to which these approaches would be cost-effective is unclear. Therefore, there is a need to define the
burden and clinical impact of respiratory viruses in the hospital setting to inform optimal diagnostic, treatment
and infection prevention strategies. The overall objective of this project is to support Josh Petrie, PhD in the
development of expertise in healthcare epidemiology, state-of-the-art molecular methods, and advanced
modeling techniques. This objective will be completed through focused training and career development
activities in healthcare epidemiology, next generation sequencing, bioinformatics, cost-effectiveness analysis,
and mathematical modeling that is overseen by an excellent team of mentors. The skills developed by the
training and career development objectives will be strengthened by mentored research to accomplish the
following Specific Aims: (1) Define the epidemiology and burden of community-acquired and hospital-
associated respiratory virus infections and compare clinical impact by viral species; (2) Improve the sensitivity
and specificity of case definitions to identify hospital-associated influenza cases by integrating clinical,
epidemiologic, and molecular data; and (3) Determine the cost-effectiveness of increased respiratory virus
screening and expanded infection control measures to reduce HA-RVI using mathematical models. Completion
of the training and research programs will represent the next step on Dr. Petrie's path toward achieving his
long term goal of establishing an independent research program that uses multidisciplinary laboratory and
analytic methodologies to investigate the transmission of influenza and other respiratory viruses. The expected
research outcomes of the proposed project are, 1) identification of respiratory viruses that, in addition to
influenza, are responsible for the greatest number of HA-RVI and result in the most severe clinical outcomes;
2) development of methodology for improved identification of HA-RVI through integration of clinical,
epidemiologic, and molecular data; and 3) determination of cost-effective diagnostic testing and intervention
implementation strategies for HA-RVI prevention. The proposed research is significant because it is expected
that the outcomes of this work and future studies that build upon it, will lead to reductions in morbidity,
mortality, and healthcare costs associated with HA-RVI. This research is innovative both in its focus on a large
panel of important respiratory viruses and its use of cross-disciplinary methodology that allows for new
avenues of research.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/cid/ciab395
发表时间:
2021-10-05
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
[Malosh RE, Petrie JG, Callear A, Truscon R, Johnson E, Evans R, Bazzi L, Cheng C, Thompson MS, Martin ET, Monto AS]
通讯作者:
Monto AS
DOI:
10.1002/jmv.27982
发表时间:
2022-11
期刊:
JOURNAL OF MEDICAL VIROLOGY
影响因子:
12.7
作者:
[Petrie, Joshua G., Eisenberg, Marisa C., Lauring, Adam S., Gilbert, Julie, Harrison, Samantha M., DeJonge, Peter M., Martin, Emily T.]
通讯作者:
Martin, Emily T.
Improving antibiotic use for sinusitis and upper respiratory tract infections: A virtual-visit antibiotic stewardship initiative.
改善鼻窦炎和上呼吸道感染的抗生素使用:虚拟访问抗生素管理计划。
DOI:
10.1017/ice.2022.19
发表时间:
2022
期刊:
Infection control and hospital epidemiology
影响因子:
4.5
作者:
[Wasylyshyn,AnastasiaI, Kaye,KeithS, Chen,Julia, Haddad,Haley, Nagel,Jerod, Petrie,JoshuaG, Gandhi,TejalN, Petty,LindsayA]
通讯作者:
Petty,LindsayA
DOI:
10.1093/ofid/ofad061
发表时间:
2023-02
期刊:
OPEN FORUM INFECTIOUS DISEASES
影响因子:
4.2
作者:
[Wan, Tiffany, Lauring, Adam S., Valesano, Andrew L., Fitzsimmons, William J., Bendall, Emily E., Kaye, Keith S., Petrie, Joshua G.]
通讯作者:
Petrie, Joshua G.
DOI:
10.1093/infdis/jiab215
发表时间:
2021-10-28
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[Dimcheff DE, Valesano AL, Rumfelt KE, Fitzsimmons WJ, Blair C, Mirabelli C, Petrie JG, Martin ET, Bhambhani C, Tewari M, Lauring AS]
通讯作者:
Lauring AS
共 8 条
Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions
-
批准号:10083176
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2019
-
负责人:Joshua Glenn Petrie
-
依托单位:
Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions - COVID-19 Administrative Supplement
-
批准号:10265668
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2019
-
负责人:Joshua Glenn Petrie
-
依托单位:
海外基金